Douglas A. Lauffenburger, PhD LinkedIn Chair, Scientific Advisory Board Science Advisory Board Key Research Systematic in silico analysis of clinically tested drugs for reducing amyloid-beta plaque accumulation in Alzheimer's disease All publications